Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS

[1]  Liang Li,et al.  Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis , 2011, Autophagy.

[2]  R. de Cabo,et al.  Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  Giovanni Manfredi,et al.  Mitochondrial dysfunction and intracellular calcium dysregulation in ALS , 2010, Mechanisms of Ageing and Development.

[4]  Di Chen,et al.  With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. , 2010, Cell metabolism.

[5]  Arlan Richardson,et al.  Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. , 2010, The Journal of biological chemistry.

[6]  M. Tarnopolsky,et al.  Caloric Restriction Shortens Lifespan through an Increase in Lipid Peroxidation, Inflammation and Apoptosis in the G93A Mouse, an Animal Model of ALS , 2010, PloS one.

[7]  Chen-Yu Liao,et al.  Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening , 2010, Aging cell.

[8]  B. Kennedy,et al.  The TOR pathway comes of age. , 2009, Biochimica et biophysica acta.

[9]  B. Kennedy,et al.  Ageing: A midlife longevity drug? , 2009, Nature.

[10]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[11]  Liou Y Sun,et al.  Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  D. Borchelt,et al.  MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models , 2008, Muscle & nerve.

[13]  R. A. Miller,et al.  Design of aging intervention studies: the NIA interventions testing program , 2008, AGE.

[14]  M. Tarnopolsky,et al.  Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn‐SOD mutant G93A mice , 2006, Muscle & nerve.

[15]  D. Rubinsztein,et al.  Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.

[16]  P. Reddy,et al.  Neuronal protection by sirtuins in Alzheimer's disease , 2006, Journal of neurochemistry.

[17]  M. Tarnopolsky,et al.  Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn‐superoxide dismutase mutant G93A mouse , 2005, Muscle & nerve.

[18]  A. Bokov,et al.  The role of oxidative damage and stress in aging , 2004, Mechanisms of Ageing and Development.

[19]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[20]  D. Borchelt,et al.  Fibrillar Inclusions and Motor Neuron Degeneration in Transgenic Mice Expressing Superoxide Dismutase 1 with a Disrupted Copper-Binding Site , 2002, Neurobiology of Disease.

[21]  M. Mattson,et al.  No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice , 1999, Brain Research.